FindTrial
Sign In

Study of a Phakic Implantable Collamer Lens (ICL)

Proof of Concept Study of a Diffractive Trifocal Phakic Implantable Collamer Lens (ICL) in Presbyopes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07790965
Enrollment
10
Registered
2026-08-27
Start date
2026-11-01
Completion date
2027-05-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Interventions

DEVICEPhakic Implantable Collamer Lens (ICL)

Diffractive Trifocal Phakic ICL

Sponsors

Staar Surgical Company
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Must be between the age of 21 - 60 years * Must be suitable for ICL surgery, * Must meet all unique study eligibility criteria

Exclusion criteria

* Outside the age of 21 - 60 years, * Not a suitable candidate for ICL surgery, * Does not meet all unique study eligibility criteria

Design outcomes

Primary

MeasureTime frameDescription
Cumulative and Persistent Adverse Events3 MonthsSafety Population

Contacts

CONTACTLaura Director, Clinical Affairs
lschall@staar.com336-306-0587
CONTACTJennifer Lynch
jlynch@staar.com
PRINCIPAL_INVESTIGATORGabriel Quesada Larez, MD

Clinica Quesada SA de CV

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026